nervous system
• sparse deposits observed at 21 weeks of age, however, numerous deposits are observed at 45 and 60 weeks
(J:113199)
• deposits are more extensive in females
(J:113199)
• level of brain amyloid beta peptide 42 is predominant over 40; levels increase dramatically after 20 weeks of age
(J:113199)
• senile plaques detected by thioflavin S or the anti-amyloid beta antibody, 3D6, as early as 4 months of age
(J:113200)
• plaques are restricted to cortex and hippocampus at time points up to 12 months of age
(J:113200)
• plaques increase in number and size over time
(J:113200)
• exhibits an overall increase in soluble and insoluble amyloid beta peptide 40 and 42 between 4 and 12 months
(J:113200)
• insoluble amyloid beta42 is increased 2-fold in cerebrum of sucrose-fed mice as compared to water-fed control
(J:129021)
• total amyloid beta levels are increased by 3.6 fold in sucrose fed mice
(J:129021)
• amyloid beta deposition is increased by 2.9-fold as determined by immunohistochemical and morphometric analysis in sucrose-fed mice
(J:129021)
|
• exhibits progressive increase in cerebral amyloid angiopathy as early as 6 months
• amyloid deposition is observed in leptomeningeal vasculature
|
behavior/neurological
• transgenic mice fed sucrose water failed to learn Morris water maze test after 5 days of training
• water-fed transgenic mice retained some learning ability over 5 day test period, but did not perform as well in the water maze test as non-transgenic controls
|
• mice fed sucrose water exhibited increased water consumption
|
homeostasis/metabolism
amyloidosis
(
J:129021
)
• sparse deposits observed at 21 weeks of age, however, numerous deposits are observed at 45 and 60 weeks
(J:113199)
• deposits are more extensive in females
(J:113199)
• level of brain amyloid beta peptide 42 is predominant over 40; levels increase dramatically after 20 weeks of age
(J:113199)
• senile plaques detected by thioflavin S or the anti-amyloid beta antibody, 3D6, as early as 4 months of age
(J:113200)
• plaques are restricted to cortex and hippocampus at time points up to 12 months of age
(J:113200)
• plaques increase in number and size over time
(J:113200)
• exhibits an overall increase in soluble and insoluble amyloid beta peptide 40 and 42 between 4 and 12 months
(J:113200)
• insoluble amyloid beta42 is increased 2-fold in cerebrum of sucrose-fed mice as compared to water-fed control
(J:129021)
• total amyloid beta levels are increased by 3.6 fold in sucrose fed mice
(J:129021)
• amyloid beta deposition is increased by 2.9-fold as determined by immunohistochemical and morphometric analysis in sucrose-fed mice
(J:129021)
|
• exhibits progressive increase in cerebral amyloid angiopathy as early as 6 months
• amyloid deposition is observed in leptomeningeal vasculature
|
• fasting plasma insulin levels are increased 3 fold in mice fed sucrose water as compared to water-fed control
|
• total cholesterol, but not HDL, levels are increased 30% in mice fed sucrose water as compared to water-fed control
|
• elevated plasma triglyceride levels observed in females at 15 weeks of age
|
• mice fed sucrose water displayed an impaired glucose tolerance as compared to water-fed control
|
cardiovascular system
growth/size/body
• mice fed sucrose water consistently gained weight over study time period (2 months- 8 months)
• sucrose-fed mice increased body weight by 17% over water-fed controls
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Alzheimer's disease | DOID:10652 | J:113199 | ||
Alzheimer's disease 3 | DOID:0110042 |
OMIM:607822 |
J:113199 |